Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (111-120 of 395) with videos related to

Pageof 40
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 8, 2020
The Effects of Tau, Amyloid, and White Matter Lesions on Mobility, Dual Tasking, and Balance in Older PeopleMaria H Nilsson, Gro Gujord Tangen, Sebastian Palmqvist, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2011
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center populationPer Johansson, Niklas Mattsson, Oskar Hansson, et al.
Journal of Neurochemistry|October 24, 2007
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosisNiklas Mattsson, Ulla Rüetschi, Vladimir N Podust, et al.
JIMD Reports|February 23, 2013
Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type CNiklas Mattsson, Henrik Zetterberg, Simona Bianconi, et al.
JAMA Neurology|November 3, 2015
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionHenrik Zetterberg, Tobias Skillbäck, Niklas Mattsson, et al.
Neuromolecular Medicine|April 18, 2014
Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndromeErik Portelius, Mikko Hölttä, Hilkka Soininen, et al.
Neurobiology of Aging|October 7, 2016
Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairmentPhilip S Insel, Michael C Donohue, R Scott Mackin, et al.
Brain Injury|May 9, 2015
Serum visinin-like protein-1 in concussed professional ice hockey playersPashtun Shahim, Niklas Mattsson, Elizabeth M Macy, et al.
Neurobiology of Aging|October 8, 2013
Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adultsNiklas Mattsson, Philip Insel, Rachel Nosheny, et al.
Annals of Clinical and Translational Neurology|August 12, 2020
Comparing progression biomarkers in clinical trials of early Alzheimer's diseaseNicholas C Cullen, Henrik Zetterberg, Philip S Insel, et al.
Pageof 40

Showing results (111-120 of 395) with videos related to

Sort By:
Pageof 40
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 8, 2020
The Effects of Tau, Amyloid, and White Matter Lesions on Mobility, Dual Tasking, and Balance in Older PeopleMaria H Nilsson, Gro Gujord Tangen, Sebastian Palmqvist, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2011
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center populationPer Johansson, Niklas Mattsson, Oskar Hansson, et al.
Journal of Neurochemistry|October 24, 2007
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosisNiklas Mattsson, Ulla Rüetschi, Vladimir N Podust, et al.
JIMD Reports|February 23, 2013
Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type CNiklas Mattsson, Henrik Zetterberg, Simona Bianconi, et al.
JAMA Neurology|November 3, 2015
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionHenrik Zetterberg, Tobias Skillbäck, Niklas Mattsson, et al.
Neuromolecular Medicine|April 18, 2014
Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndromeErik Portelius, Mikko Hölttä, Hilkka Soininen, et al.
Neurobiology of Aging|October 7, 2016
Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairmentPhilip S Insel, Michael C Donohue, R Scott Mackin, et al.
Brain Injury|May 9, 2015
Serum visinin-like protein-1 in concussed professional ice hockey playersPashtun Shahim, Niklas Mattsson, Elizabeth M Macy, et al.
Neurobiology of Aging|October 8, 2013
Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adultsNiklas Mattsson, Philip Insel, Rachel Nosheny, et al.
Annals of Clinical and Translational Neurology|August 12, 2020
Comparing progression biomarkers in clinical trials of early Alzheimer's diseaseNicholas C Cullen, Henrik Zetterberg, Philip S Insel, et al.
Pageof 40